Literature DB >> 17406963

Hydrazine and amphetamine binding to amine oxidases: old drugs with new prospects.

P Knowles1, C Kurtis, J Murray, C Saysell, W Tambyrajah, C Wilmot, M McPherson, S Phillips, D Dooley, D Brown, M Rogers, M Mure.   

Abstract

Tranylcypromine (TCP), an amphetamine, is a reversible inhibitor of copper-containing amine oxidases. We have solved the structure of the complex of TCP with the amine oxidase from E. coli (ECAO) and shown that only the (+)-enantiomer of TCP binds. Kinetic studies on 2-phenylethylamine and TCP binding to wild-type ECAO and mutational variants fully support the model in which binding of the protonated amine is the first step in the catalytic cycle. Hydrazines are irreversible inhibitors of copper-containing amine oxidases. Binding of hydrazines leads to an adduct ("Adduct 1") with a chromophore at 430 nm which converts at higher pH to another adduct ("Adduct 2") with a chromophore at 520 nm. We have determined the structures of Adduct 1 and 2 for 2-hydrazinopyridine reacted with ECAO. It has been found that Adduct 1 corresponds to the hydrazone and azo tautomers whilst Adduct 2 corresponds to the azo tautomer coordinated to the active site copper. The implications of these results in developing more specific drugs are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406963     DOI: 10.1007/s00702-007-0681-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  24 in total

1.  A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase.

Authors:  S M Janes; D Mu; D Wemmer; A J Smith; S Kaur; D Maltby; A L Burlingame; J P Klinman
Journal:  Science       Date:  1990-05-25       Impact factor: 47.728

2.  Medical implications from the crystal structure of a copper-containing amine oxidase complexed with the antidepressant drug tranylcypromine.

Authors:  Carrie M Wilmot; Colin G Saysell; Aidan Blessington; Danyl A Conn; Christian R Kurtis; Michael J McPherson; Peter F Knowles; Simon E V Phillips
Journal:  FEBS Lett       Date:  2004-10-22       Impact factor: 4.124

3.  Origins of plasma amine oxidases in different mammalian species.

Authors:  H G Schwelberger
Journal:  Inflamm Res       Date:  2006-04       Impact factor: 4.575

4.  Lysyl oxidase and rrg messenger RNA.

Authors:  K Kenyon; S Contente; P C Trackman; J Tang; H M Kagan; R M Friedman
Journal:  Science       Date:  1991-08-16       Impact factor: 47.728

5.  Half-of-the-sites reactivity of bovine serum amine oxidase. Reactivity and chemical identity of the second site.

Authors:  D De Biase; E Agostinelli; G De Matteis; B Mondovì; L Morpurgo
Journal:  Eur J Biochem       Date:  1996-04-01

6.  Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity.

Authors:  Eric Y Wang; Hongfeng Gao; Luisa Salter-Cid; Jun Zhang; Li Huang; Erika M Podar; Andrew Miller; Jingjing Zhao; Anne O'rourke; Matthew D Linnik
Journal:  J Med Chem       Date:  2006-04-06       Impact factor: 7.446

7.  Antidepressant efficacy of tranylcypromine isomers: a controlled study.

Authors:  H W Moises; H Beckmann
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

8.  Plasma tranylcypromine: relationship to pharmacokinetic variables and clinical antidepressant actions.

Authors:  A G Mallinger; J M Himmelhoch; M E Thase; D J Edwards; S Knopf
Journal:  J Clin Psychopharmacol       Date:  1990-06       Impact factor: 3.153

9.  The pharmacokinetics of tranylcypromine enantiomers in healthy subjects after oral administration of racemic drug and the single enantiomers.

Authors:  H Weber-Grandke; G Hahn; E Mutschler; W Möhrke; P Langguth; H Spahn-Langguth
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

10.  Active site rearrangement of the 2-hydrazinopyridine adduct in Escherichia coli amine oxidase to an azo copper(II) chelate form: a key role for tyrosine 369 in controlling the mobility of the TPQ-2HP adduct.

Authors:  Minae Mure; Christian R Kurtis; Doreen E Brown; Melanie S Rogers; Winston S Tambyrajah; Colin Saysell; Carrie M Wilmot; Simon E V Phillips; Peter F Knowles; David M Dooley; Michael J McPherson
Journal:  Biochemistry       Date:  2005-02-08       Impact factor: 3.162

View more
  1 in total

1.  Complexes of the copper-containing amine oxidase from Arthrobacter globiformis with the inhibitors benzylhydrazine and tranylcypromine.

Authors:  David B Langley; Daniel M Trambaiolo; Anthony P Duff; David M Dooley; Hans C Freeman; J Mitchell Guss
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-06-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.